Investigating immune responses to Chlamydia vaccine candidates in women
Host Immune Responses to Chlamydia trachomatis Candidate Vaccine Antigens and their Association with Clinical Correlates of Protective Immunity in Women
This study is looking at how women's immune systems react to different parts of the Chlamydia bacteria to help find a vaccine that can protect against this common infection and its serious health effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10828344 on NIH RePORTER |
What this research studies
This research focuses on understanding how the immune system responds to potential vaccine candidates for Chlamydia trachomatis, a common sexually transmitted infection that can lead to serious reproductive health issues. By analyzing immune responses in women, particularly through the study of mucosal mononuclear cells from menstrual blood, the researchers aim to identify which components of the Chlamydia bacteria can effectively stimulate protective immunity. The study also explores the relationship between immune responses and clinical outcomes, such as the ability to clear the infection and prevent reinfection. This comprehensive approach could provide critical insights into the development of an effective vaccine against Chlamydia.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who are at risk of Chlamydia trachomatis infection or have a history of Chlamydia infections.
Not a fit: Patients who are not at risk for Chlamydia infections or those who have already been vaccinated against it may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a vaccine that significantly reduces the incidence of Chlamydia infections and their associated reproductive health complications in women.
How similar studies have performed: Previous research has shown promise in identifying immune correlates of protection against Chlamydia, but this specific approach to studying immune responses in women is relatively novel.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Geisler, William M — University of Alabama at Birmingham
- Study coordinator: Geisler, William M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.